ArticleIJID regions2026
Age-stratified prevalence of latent tuberculosis infection in Ulaanbaatar, Mongolia: a facility-based cross-sectional study.
Article in IJID regions, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Mongolia has a high tuberculosis (TB) burden. This study aimed to assess the age-specific latent TB infection (LTBI) prevalence in a healthy population in Mongolia by using interferon-gamma release assays. Methods: This facility-based cross-sectional study was conducted from June 2024 to March 2025 in Ulaanbaatar. Eligible participants were asymptomatic, aged ≥10 years, had no previous TB treatment, and had no known contact with TB. LTBI was detected using the QuantiFERON-TB Gold Plus (QFT-Plus) assay. Sociodemographic data were collected using standardized questionnaires. Results: The overall QFT-Plus positivity rate in 766 eligible participants (mean age: 38.2 years; 47.1% female) was 33.4%. Age-specific positivity increased from 7.9% (participants aged 10-19 years) to 46.1% (participants aged ≥60 years, Conclusion: Ulaanbaatar's LTBI prevalence remains high, especially among older adults, suggesting a shift from recent transmission to remote infection reactivation. Although QFT-Plus positivity in young individuals remains high, our findings support the prioritization of targeted preventive strategies for older populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.